185 related articles for article (PubMed ID: 37838774)
81. Functional characterization of a chimeric soluble Fas ligand polymer with in vivo anti-tumor activity.
Daburon S; Devaud C; Costet P; Morello A; Garrigue-Antar L; Maillasson M; Hargous N; Lapaillerie D; Bonneu M; Dechanet-Merville J; Legembre P; Capone M; Moreau JF; Taupin JL
PLoS One; 2013; 8(1):e54000. PubMed ID: 23326557
[TBL] [Abstract][Full Text] [Related]
82. [Expression Fas and FasL antigen protein of lymphocytes T and B in hypertrophied adenoid in children with otitis media with effusion].
Zelazowska-Rutkowska B; Wysocka J; Ratomski K; Skotnicka B; Zak J; Mrugacz M
Otolaryngol Pol; 2008; 62(1):59-64. PubMed ID: 18637423
[TBL] [Abstract][Full Text] [Related]
83. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
Straus SE; Jaffe ES; Puck JM; Dale JK; Elkon KB; Rösen-Wolff A; Peters AM; Sneller MC; Hallahan CW; Wang J; Fischer RE; Jackson CE; Lin AY; Bäumler C; Siegert E; Marx A; Vaishnaw AK; Grodzicky T; Fleisher TA; Lenardo MJ
Blood; 2001 Jul; 98(1):194-200. PubMed ID: 11418480
[TBL] [Abstract][Full Text] [Related]
84. Cloning and expression of a short Fas ligand: A new alternatively spliced product of the mouse Fas ligand gene.
Ayroldi E; D'Adamio F; Zollo O; Agostini M; Moraca R; Cannarile L; Migliorati G; Delfino DV; Riccardi C
Blood; 1999 Nov; 94(10):3456-67. PubMed ID: 10552956
[TBL] [Abstract][Full Text] [Related]
85. A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potency.
Chodorge M; Züger S; Stirnimann C; Briand C; Jermutus L; Grütter MG; Minter RR
Cell Death Differ; 2012 Jul; 19(7):1187-95. PubMed ID: 22261618
[TBL] [Abstract][Full Text] [Related]
86. Fas/FasL signaling is critical for the survival of exhausted antigen-specific CD8
Yajima T; Hoshino K; Muranushi R; Mogi A; Onozato R; Yamaki E; Kosaka T; Tanaka S; Shirabe K; Yoshikai Y; Kuwano H
Mol Immunol; 2019 Mar; 107():97-105. PubMed ID: 30711908
[TBL] [Abstract][Full Text] [Related]
87. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
Koshkina N; Yang Y; Kleinerman ES
Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
[TBL] [Abstract][Full Text] [Related]
88. HIV-induced apoptosis of activated primary CD4+ T lymphocytes is not mediated by Fas-Fas ligand.
Noraz N; Gozlan J; Corbeil J; Brunner T; Spector SA
AIDS; 1997 Nov; 11(14):1671-80. PubMed ID: 9386801
[TBL] [Abstract][Full Text] [Related]
89. Effective Targeting of TAG72
Murad JP; Kozlowska AK; Lee HJ; Ramamurthy M; Chang WC; Yazaki P; Colcher D; Shively J; Cristea M; Forman SJ; Priceman SJ
Front Immunol; 2018; 9():2268. PubMed ID: 30510550
[TBL] [Abstract][Full Text] [Related]
90. Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.
Martin DA; Zheng L; Siegel RM; Huang B; Fisher GH; Wang J; Jackson CE; Puck JM; Dale J; Straus SE; Peter ME; Krammer PH; Fesik S; Lenardo MJ
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4552-7. PubMed ID: 10200300
[TBL] [Abstract][Full Text] [Related]
91. Examination of the sensitivity of T cells to Fas ligation: induction of allospecific apoptosis.
O'Flaherty E; Ali S; Pettit SJ; Kirby JA
Transplantation; 1998 Oct; 66(8):1067-73. PubMed ID: 9808493
[TBL] [Abstract][Full Text] [Related]
92. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids.
Yang Y; Merćep M; Ware CF; Ashwell JD
J Exp Med; 1995 May; 181(5):1673-82. PubMed ID: 7536793
[TBL] [Abstract][Full Text] [Related]
93. Sensitization of p53-mutated epithelial ovarian cancer to CD95-mediated apoptosis is synergistically induced by cisplatin pretreatment.
Bagnoli M; Balladore E; Luison E; Alberti P; Raspagliesi F; Marcomini B; Canevari S; Mezzanzanica D
Mol Cancer Ther; 2007 Feb; 6(2):762-72. PubMed ID: 17308072
[TBL] [Abstract][Full Text] [Related]
94. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
[TBL] [Abstract][Full Text] [Related]
95. HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes.
Truman JP; Choqueux C; Tschopp J; Vedrenne J; Le Deist F; Charron D; Mooney N
Blood; 1997 Mar; 89(6):1996-2007. PubMed ID: 9058721
[TBL] [Abstract][Full Text] [Related]
96. Fas ligand is localized to membrane rafts, where it displays increased cell death-inducing activity.
Cahuzac N; Baum W; Kirkin V; Conchonaud F; Wawrezinieck L; Marguet D; Janssen O; Zörnig M; Hueber AO
Blood; 2006 Mar; 107(6):2384-91. PubMed ID: 16282344
[TBL] [Abstract][Full Text] [Related]
97. Molecular genetic studies in lymphocyte apoptosis and human autoimmunity.
Martin DA; Combadiere B; Hornung F; Jiang D; McFarland H; Siegel R; Trageser C; Wang J; Zheng L; Lenardo MJ
Novartis Found Symp; 1998; 215():73-82; discussion 82-91. PubMed ID: 9760572
[TBL] [Abstract][Full Text] [Related]
98. Characterizing the regulatory Fas (CD95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer.
Mondal T; Gaur H; Wamba BEN; Michalak AG; Stout C; Watson MR; Aleixo SL; Singh A; Condello S; Faller R; Leiserowitz GS; Bhatnagar S; Tushir-Singh J
Cell Death Differ; 2023 Nov; 30(11):2408-2431. PubMed ID: 37838774
[TBL] [Abstract][Full Text] [Related]
99. A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy.
Upadhyay R; Boiarsky JA; Pantsulaia G; Svensson-Arvelund J; Lin MJ; Wroblewska A; Bhalla S; Scholler N; Bot A; Rossi JM; Sadek N; Parekh S; Lagana A; Baccarini A; Merad M; Brown BD; Brody JD
Cancer Discov; 2021 Mar; 11(3):599-613. PubMed ID: 33334730
[TBL] [Abstract][Full Text] [Related]
100. A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.
Del-Rey M; Ruiz-Contreras J; Bosque A; Calleja S; Gomez-Rial J; Roldan E; Morales P; Serrano A; Anel A; Paz-Artal E; Allende LM
Blood; 2006 Aug; 108(4):1306-12. PubMed ID: 16627752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
